Canopy Growth Corp(CGC)
USD --+0.00%
Reward44Moderate
Risk76High
📊75%Data
Thin -117% profit margin
CGC
+0.0 · +0.00%
USD · NASDAQ
Canopy Growth Corp | Healthcare
Earnings Deterioration
Market Cap:478.43M
ℹ️
Reward Rating
44
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
76
High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CGC to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: C$1.79.

What is Canopy Growth Corp?

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

CGC · Verdict

Moderate reward · high risk

CGC's standout is valuation; volatility and profitability weigh on the picture.

Based on 88% data coverage

CGC · Verdict

What’s working & what to watch

Strengths 1

  • Valuation75/100

    P/E 20.4×

Watchouts 3

  • Volatility5/100

    Weak vs peers

  • Profitability9/100

    -222% net margin · -49% ROE

  • Cash flow9/100

    -66% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is Canopy Growth Corp?

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 478.43M.

Financial Highlights

Investment Breakdown

📈 Growth
Growth trend is developing — watch for revenue consistency over upcoming quarters.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Elevated volatility implies higher downside and expectation risk.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (44)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap478.43M
P/E RatioN/A
Dividend YieldN/A
52 Week High2.38
52 Week Low0.77
Last AnnualMarch
IPO Date4/4/2014
IncorporatedUSA
Shares Outstanding378M
No. of Employees960
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNASDAQ
Beta2.398
CurrencyUSD · Reports in CAD